ClinicalTrialsFinder

Glioblastoma Multiforme (GBM) Clinical Trials in The Bronx, New York

1 recruitingThe Bronx, New York

Showing 1–1 of 1 trials

Recruiting
Phase 2

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Central Nervous System DiseasesBrain CancerGlioblastoma Multiforme (GBM)+4 more
Black Diamond Therapeutics, Inc.162 enrolled13 locationsNCT07326566